Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

DFE Pharma, Harro Höfliger, and Sterling Partner to Provide Formulation Services for Respiratory Products

March 25, 2022

DFE Pharma, Harro Höfliger, and Sterling have announced a partnership called Inhalation Together to provide formulation services for respiratory products.

Gamma Biosciences and Mirus Bio to Develop Lipid-Polymer Nanocomplexes

March 24, 2022

Gamma Biosciences has announced an initiative through its subsidiary, Mirus Bio, to develop lipid-polymer nanocomplexes for improve mRNA delivery solutions.

physIQ and CellCarta Collaborate on Personalized Approach to Vaccine Development

March 21, 2022

physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.

Sanofi Announces €300 million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

March 18, 2022

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

Sanofi and Seagen Announce ADC Development Collaboration

March 18, 2022

Sanofi and Seagen have entered an agreement to investigate three cancer targets.

Catalent Completes $30 Million Project for Biopharmaceutical Development and Manufacturing in Limoges, France

March 17, 2022

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.

NIH Launches Clinical Trial of Three mRNA HIV Vaccines

March 16, 2022

NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.

FDA Grants Orphan Drug Designation to Soft Tissue Sarcoma Treatment

March 11, 2022

C4 Therapeutics has been granted orphan drug designation by FDA for CFT8634 for the treatment of soft tissue sarcoma.

SCG Cell Therapy and A*STAR’s BTI Collaborate to Advance Multi-Specific Antibody Development

March 11, 2022

SCG Cell Therapy has signed a collaboration agreement with A*STAR’s BTI to advance the development of antibodies for infectious diseases and cancer treatments.

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

March 10, 2022

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.